Home » News » Drug Sponsors » Frontage Laboratories collaborates with Yabao Pharmaceuticals Group

Frontage Laboratories collaborates with Yabao Pharmaceuticals Group

Tuesday, March 1, 2011

Frontage Laboratories has signed a $50 million collaboration with China’s Yabao Pharmaceuticals Group, under which Frontage will supply pharmaceutical and regulatory development services to Yabao over five years, according to PharmaTimes.

The U.S.-based contract research, development and manufacturing group, which has a substantial presence in China, will develop sustained-release drug technologies for Yabao and provide clinical research support for its efforts to develop 20 new products for the U.S. and E.U. markets. Frontage established a subsidiary in Shanghai in 2006 and a clinical research center in Zhengzhou in 2009, and is currently completing construction of a drug development operation in Beijing.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!